Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome - Blom, D J; Koren, M J; Roth, E (Diabetes Obes Metab, 2017)
et al.